Granted Patent B2

US 12,274,877 · App. 17/767,409 · Granted Apr 15, 2025

Inventors: Jose M. Carmena (Alameda, CA); Michel M. Maharbiz (El Cerrito, CA); Ryan Neely (El Cerrito, CA); Joshua Kay (Oakland, CA); Giana Montero Garnier (Berkeley, CA)

Assignee: IOTA BIOSCIENCES, INC.

A61N1/36002A61N1/3606A61N1/36139A61N1/36157A61N1/36171A61N1/36178A61N1/37217A61N1/3787A61N1/0556

Abstract

Claims (20)

1. A method of treating a cancer in a subject, comprising:

electrically stimulating the splenic nerve of the subject using a fully implanted device comprising one or more electrodes in electrical communication with the splenic nerve sufficient to increase activation or circulation of natural killer (NK) cells of the subject and treat the cancer in the subject.

2. The method of claim 1 , wherein the immune system is modulated to increase activation of one or more other immune cells in the subject.

3. The method of claim 2 , wherein the immune system is modulated to increase activation of cytotoxic T-cells in the subject.

4. The method of claim 1 , wherein the splenic nerve is electrically stimulated with a plurality of electrical pulses emitted at a frequency of less than 25 Hz.

5. The method of claim 1 , wherein the splenic nerve is electrically stimulated with a plurality of electrical pulses emitted at a frequency of about 3 Hz to about 20 Hz.

6. The method of claim 1 , comprising:

receiving, at the device, ultrasonic waves from an external ultrasonic transducer; and

converting energy from the ultrasonic waves into electrical energy that powers the device.

7. The method of claim 6 , comprising transmitting the ultrasonic waves that power the implanted device using an external device.

8. The method of claim 1 , wherein the splenic nerve is electrically stimulated using one or more electrical pulses about 5 ms in length or less.

9. The method of claim 1 , wherein the splenic nerve is electrically stimulated using one or more electrical pulses having an amplitude of about 250 μA to about 50 mA.

10. The method claim 3 , wherein the splenic nerve is electrically stimulated using one or more electrical pulses at a frequency of about 100 Hz or less.

11. The method of claim 1 , wherein the splenic nerve is electrically stimulated using a pulse train comprising a plurality of biphasic electrical pulses.

12. The method of claim 11 , wherein the biphasic electrical pulses comprises an anodal phase followed by a cathodal phase.

13. The method of claim 11 , wherein the biphasic electrical pulses comprises a cathodal phase followed by an anodal phase.

14. The method of claim 1 , wherein the splenic nerve is electrically stimulated using a plurality of pulse trains comprising two or more electrical pulses, the pulse trains separated by a dwell time of about 50 ms or more.

15. The method of claim 14 , wherein the plurality of pulse trains comprises at least a first pulse train followed by a second pulse train, wherein electrical pulses in the first pulse train have an amplitude lower than an amplitude of electrical pulses in the second pulse train.

16. The method of claim 1 , wherein the splenic nerve is electrically stimulated using tonic electrical pulses.

17. The method of claim 1 , wherein the implanted device is fully implanted with in within the perivascular fascia surrounding the splenic nerve and splenic artery.

Assignments (1)

Continuity (2)

References Cited (400)